ACE Inhibitors Market Size, Share, Trends & Forecast
The ACE Inhibitors Market is developing steadily as healthcare systems continue to address hypertension, heart failure, chronic kidney disease, and other cardiovascular conditions. ACE inhibitors are established medicines used in the management of several conditions, supporting consistent demand across healthcare settings.
Hypertension remains a major application area for ACE inhibitors. Drugs such as lisinopril, enalapril, ramipril, and captopril are among the therapies used in cardiovascular care. Growing awareness of blood pressure management and the increasing burden of chronic disease are contributing to continued market relevance.
The aging population is another factor influencing demand. Older adults have a higher prevalence of cardiovascular and related chronic conditions, creating an ongoing need for long-term treatment options and routine medical monitoring.
Generic medicines are also important to the market. The availability of established ACE inhibitor therapies from multiple manufacturers can support affordability and wider access to treatment.
According to Market Research Future, the global ACE inhibitors market was valued at USD 5.55 billion in 2024 and is projected to reach USD 8.02 billion by 2035, reflecting a 3.4% CAGR during 2025–2035.